Oxycodone vs Sufentanil for Laparoscopic Hysterectomy
Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy
- Age
- 18 – 65
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 64 (estimated)
- Sponsor
- Affiliated Hospital of Nantong University · Other
This trial is looking for women aged 18 to 65 who are undergoing laparoscopic hysterectomy. Participants will use patient-controlled pain medication during their recovery after surgery.
You may be able to join if
- I am having a selective laparoscopic hysterectomy
- I will receive general anesthesia
- I am classified as ASA I, II, or III
- I am between 18 and 65 years old
You may not be able to join if
- I am allergic to oxycodone or other study drugs
- I have taken opioids before the surgery
- I have a history of opioid abuse
- I have liver dysfunction
- I have kidney dysfunction
- I have cardiovascular dysfunction
- I have pulmonary dysfunction
- I do not have full civil capacity or refuse to participate
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis study is designed to evaluate the efficacy and safety of hydrocodone in patient-controlled intravenous analgesia (PCIA) during gynecological laparoscopy, thus to explore suitable PCIA scheme to optimize postoperative pain management for patients undergoing gynecological laparoscopic surgeries.
Loading trial locations…